Countdown To Compliance: New UK Clinical Trial Transparency Requirements

As of April 28, 2026, transparency is no longer a goal for the UK clinical trial landscape—it is a legal mandate. New regulations introduce strict registration timelines and results publication requirements, backed by the weight of criminal penalties for non-compliance. This shift requires sponsors and clinical operations teams to move beyond ad-hoc reporting and establish robust, sustainable transparency workflows as well as a clear understanding of both the regulatory intent and operational reality. By examining the updated framework through the eyes of regulators and registry experts, professionals can identify specific gaps in their current processes.

Learn more as the focus shifts toward practical readiness: building the systems and medical writing capabilities needed to meet these obligations. This presentation explores the updated framework that ensures that trial portfolios remain compliant while upholding the core mission of participant-centered research.